Chronic Lymphocytic Leukemia

Showing NaN - NaN of 108

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Completed
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +105 more
Mar 2, 2020

Chronic Lymphocytic Leukemia Trial in Houston (Ibrutinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 25, 2020

Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide)

Completed
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 29, 2020

Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide, Fludarabine, Rituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia Trial in United States (AVL-292)

Completed
  • B Cell Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +12 more
Nov 6, 2019

Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic Trial in Worldwide (lenalidomide)

Completed
  • Chronic Lymphocytic Leukemia
  • Leukemia, B-Cell, Chronic
  • Tucson, Arizona
  • +34 more
Nov 6, 2019

Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Ublituximab + TGR-1202, Ublituximab + TGR-1202 +

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
  • Ublituximab + TGR-1202
  • +2 more
  • Huntsville, Alabama
  • +5 more
Nov 4, 2019

Anemia, Cancer Fatigue, Chronic Lymphocytic Leukemia Trial in Houston (Ex Vivo-activated Autologous Lymph Node Lymphocytes,

Completed
  • Anemia
  • +13 more
  • Ex Vivo-activated Autologous Lymph Node Lymphocytes
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 7, 2019

Chronic Lymphocytic Leukemia Trial in Philadelphia, Houston (Infusion of CD3/CD28 stimulated T cells)

Completed
  • Chronic Lymphocytic Leukemia
  • Infusion of CD3/CD28 stimulated T cells
  • Philadelphia, Pennsylvania
  • +1 more
Oct 21, 2019

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)

Terminated
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +44 more
Aug 12, 2019

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (TG02 citrate)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • TG02 citrate
  • Augusta, Georgia
  • +4 more
Jul 23, 2019

CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Houston (procedure, biological, drug)

Completed
  • CD20 Positive
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
May 30, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Placebo to match idelalisib)

Completed
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +71 more
May 1, 2019

Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 16, 2019

Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Mitoxantrone)

Completed
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 18, 2019

Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

Completed
  • Acute Leukemia
  • +8 more
  • Tacrolimus (ARM with Methotrexate)
  • +7 more
  • Duarte, California
  • +29 more
Jan 2, 2019

Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (Deoxycoformycin (DCF))

Completed
  • Peripheral T-cell Lymphoma
  • +2 more
  • Deoxycoformycin (DCF)
  • Houston, Texas
    M. D. Anderson Cancer Center
Nov 14, 2018

Leukemia, CLL, Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide)

Completed
  • Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 23, 2018

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Collecting and Storing Malignant, Borderline Malignant

Completed
  • Acute Undifferentiated Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +191 more
Jul 17, 2018

Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Fludarabine Phosphate
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 5, 2018

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Duarte, California
  • +107 more
Nov 27, 2017

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (Polatuzumab Vedotin, Rituximab)

Completed
  • Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • Stanford, California
  • +15 more
Jun 14, 2017

B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (SNS-032 Injection)

Completed
  • B-lymphoid Malignancies
  • +3 more
  • SNS-032 Injection
  • Duarte, California
  • +5 more
Apr 7, 2017